Address correspondence to Karen E. Reprints are not available from the author. The views expressed in this article are those of the author and do not necessarily reflect the official policy of the Department of the Navy, Department of Defense, or the U.
Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy. J Pediatr. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia.
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Routine transcutaneous bilirubin measurements combined with clinical risk factors improve the prediction of subsequent hyperbilirubinemia. J Perinatol. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
Preventive Services Task Force. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: U. Preventive Services Task Force recommendation statement. American Academy of Family Physicians. Clinical recommendations: hyperbilirubinemia, infants.
Accessed March 10, Systematic review of screening for bilirubin encephalopathy in neonates. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use. Association of transcutaneous bilirubin testing in hospital with decreased readmission rate for hyperbilirubinemia. Clin Chem. Cost-effectiveness of strategies that are intended to prevent kernicterus in newborn infants.
Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants. Accessed January 20, Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia. Isr Med Assoc J. Maisels MJ, Kring E. Rebound in serum bilirubin level following intensive phototherapy.
Arch Pediatr Adolesc Med. Al-Saedi SA. Rebound hyperbilirubinemia in term infants after phototherapy. Saudi Med J. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev. Akobeng AK. Neonatal jaundice. Clin Evid Concise. Numbers needed to treat with phototherapy according to American Academy of Pediatrics guidelines.
Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma. Pediatr Allergy Immunol. Dahlquist G, Kallen B. Indications that phototherapy is a risk factor for insulin-dependent diabetes.
Diabetes Care. Effect of neonatal phototherapy on melanocytic nevus count in children. Arch Dermatol. Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Jaundice, terminating breast-feeding, and the vulnerable child. Brethauer M, Carey L.
Maternal experience with neonatal jaundice. Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits. Gourley GR. Breast-feeding, neonatal jaundice and kernicterus. Semin Neonatol. Is breastfeeding really favoring early neonatal jaundice?
The impact of the maternal experience with a jaundiced newborn on the breastfeeding relationship. J Fam Pract. Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more.
N Engl J Med. The medical term for jaundice in babies is neonatal jaundice. The symptoms of newborn jaundice usually develop 2 to 3 days after the birth and tend to get better without treatment by the time the baby is about 2 weeks old.
Find out more about the symptoms of jaundice in babies. Your baby will be examined for signs of jaundice within 72 hours of being born as part of the newborn physical examination. If your baby develops signs of jaundice after this time, speak to your midwife, health visitor or a GP as soon as possible for advice. While jaundice is not usually a cause for concern, it's important to determine whether your baby needs treatment.
If you're monitoring your baby's jaundice at home, it's also important to contact your midwife straight away if your baby's symptoms quickly get worse or they become very reluctant to feed.
Find out more about diagnosing jaundice in babies. Jaundice is caused by the build-up of bilirubin in the blood. Bilirubin is a yellow substance produced when red blood cells, which carry oxygen around the body, are broken down. Jaundice is common in newborn babies because babies have a high number of red blood cells in their blood, which are broken down and replaced frequently. More Information Blood transfusion Photodynamic therapy. Request an Appointment at Mayo Clinic.
Share on: Facebook Twitter. Show references Wong RJ, et al. Clinical manifestations of unconjugated hyperbilirubinemia in term and late preterm infants. Accessed April 2, Maisels MJ, et al. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Subcommittee on Hyperbilirubinemia. American Academy of Pediatrics. Hay WW, et al. The newborn infant. New York, N. Wong RJ, et al. Evaluation of unconjugated hyperbilirubinemia in term and late preterm infants.
Maisels MJ.
0コメント